Gilead Terminates Study After Coronavirus Drug Remdesivir Fails To Improve Recovery For Covid-19

Gilead terminates study after coronavirus drug Remdesivir fails to improve recovery for COVID-19

Gilead halted after medication Remdesivir flopped in coronavirus trial

CNBC Television

Gilead Covid-19 Drug Remdesivir Fails in Chinese Trial

Bloomberg Television

COVID-19 Insights: Remdesivir Mechanism of Action

Drbeen Medical Lectures

Coronavirus Updates, April 24: Leaked Study Shows Remdesivir Ineffective Against COVID-19

Gilead CEO on promising study results for remdesivir Covid-19 treatment

CNBC Television

Remdesivir: A new drug that boosts recovery from coronavirus l How it works

Hindustan Times

Study: Gilead drug Remdesivir sped coronavirus recovery time by 31%

Fauci: Gilead's Remdesivir Drug Trials Show ‘Good News' Against Covid-19 Fight

Bloomberg Quicktake

Gilead drug remdesivir proves effective against COVID-19 in US study

Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'

Gilead drops after Remdesivir antivirus drug 'flopped' in trials

CNBC Television

Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19

CNBC Television

Gilead: Additional remdesivir data shows improved recovery

CNBC Television

Gilead Drug Remdesivir Is a Rare Example of Foresight in the Coronavirus Pandemic

Bloomberg Quicktake

Coronavirus: Remdesivir may reduce deaths in COVID-19 patients: Gilead

Remdesivir treatment for Covid-19: New Drug Review. Veklury coronavirus antiviral from Gilead.

The PharmEZ Tutor

Gilead’s Remdesivir Becomes First Covid-19 Drug to Win FDA Approval

Bloomberg Quicktake

Dr. Anthony Fauci's positive comments on using Gilead's Remdesivir to treat coronavirus

CNBC Television

NIAID trial of remdesivir met its 'primary goal': Gilead

CNBC Television